Corbion NV - Company Profile
Powered by 
All the sales intelligence you need on Corbion NV in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Corbion NV fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Corbion NV.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Corbion NV (Corbion) manufactures and supplies biochemical, biomedical, bioplastic, and food ingredient solutions. The company specializes in fermentation and application development, offering products such as lactic acid and its derivatives, food-preservation solutions, functional-ingredient systems, and algae-derived nutritional ingredients. It offers food solutions to various businesses such as bakeries, meat, confectionery, poultry, oils, dairy, seafood, shortening and margarine, beverages, fruits, and vegetables, refrigerated food and emulsifiers. Corbion caters to biochemical solutions for agrochemicals, pharma, animal health and nutrition, chemicals, home care, and personal care. The company markets its products under various brands such as AlgaPrime DHA, Starplex, Purac, AlgaVia, Verdad, Puracal, Nutrivan, and Ultra Fresh. The company operates manufacturing facilities in the US, Thailand, Brazil, Mexico, the Netherlands, and Spain, with innovation centers located globally. Corbion is headquartered in Amsterdam, Noord-Holland, the Netherlands.
Headquarters
Netherlands
Address
Piet Heinkade 127, Amsterdam, 1019GM
Website
www.corbion.com
Telephone
31 20 5906911
No of Employees
2,408
Industry
Chemicals
Ticker Symbol & Exchange
CRBN (AMS)
Revenue (2024)
$1.4B
-1.6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-61.1%
(2024 vs 2023)
Market Cap*
$1.3B
Net Profit Margin (2024)
XYZ
-60.5%
(2024 vs 2023)
* As of and is in US$
Corbion NV premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Food | Contract Manufacturing | Aloapur |
| Antioxidants | Technical Services | Calfeed |
| Fermentation and Preservation Ingredients | Co-Development | Lafeed |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In June, the company launched LUMI Set to help bakers reformulate away from titanium dioxide without sacrificing visual appeal. |
| 2025 | Contracts/Agreements | In August, the company signed a strategic partnership with Kuehnle AgroSystems to form and commercialize a high-quality, natural astaxanthin derived from non-GMO heterotrophic algae. |
| 2025 | Regulatory Approval | In July, the company secured Chinese regulatory approvals to introduce its premium algae-derived omega-3 DHA products into human and animal nutrition markets in China. |
Competitor Comparison
| Key Parameters | Corbion NV | BASF SE | DSM-Firmenich AG | Kerry Group plc | Ingredion Inc |
|---|---|---|---|---|---|
| Headquarters | Netherlands | Germany | Switzerland | Ireland | United States of America |
| City | Amsterdam | Ludwigshafen | Kaiseraugst | Tralee | Westchester |
| State/Province | - | Rheinland-Pfalz | Aargau | Kerry | Illinois |
| No. of Employees | 2,408 | 106,428 | 28,550 | 19,961 | 11,200 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ilona Haaijer | Vice Chairman | Executive Board | 2020 | 57 |
| Olivier Rigaud | Chief Executive Officer | Senior Management | 2023 | 62 |
| Peter Kazius | Chief Financial Officer | Senior Management | 2024 | 54 |
| Yves Boland | Chief Technology Officer | Senior Management | 2025 | 47 |
| Masha Vis-Mertens | Chief Human Resources Officer | Senior Management | 2024 | 55 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer